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Abstract
Seven conventional adult horses were inoculated intranasally with a
Brazilian A4/72 strain of  equid herpesvirus-1 (EHV-1).  In the first
ten days after the inoculation, they showed signs of a mild, self-
limiting upper respiratory tract infection. In spite of the presence of
neutralizing antibodies before the trial, seroconversion was observed
in some horses.  The virus was not isolated from nasal swabs and
peripheral blood leukocytes (PBL) of any of the horses.  However,
the EHV-1 was detected through the polymerase chain reaction (PCR)
from PBL of all horses in the experiment within the third to the
eighth day after the inoculation that illustrated the viremia.  In addition,
the PCR assay also detected the virus in bronchoalveolar lavage fluid
samples starting on the ninth day after the experimental infection in
most of horses.  For that reason, as a diagnostic tool, the PCR assay
showed higher sensitivity and specificity than the conventional








Equid herpesvirus-1 (EHV-1) and 4
(EHV-4), both serologically cross-related
alpha herpesviruses, are important causes of
upper respiratory tract (URT) disease in
horses, known as equine rhinopneumonitis
(ER).  Furthermore, the EHV-1, as an
etiologic agent, has also been related to other
different forms of  disease, such as abortion
in pregnant mares, perinatal foal death, and
myeloencephalopathy.1,2
EHV-1 is believed to be ubiquitous
in horse populations worldwide and also
disseminated in Brazil.2,3  Additionally, the
EHV-1 infection, which has had devastating
effects on breeding farms and in
performance horses, may result in substantial
financial losses to the equine industry.1
Therefore, the diagnostic tools for ER must
be rapid and sensitive so that early
intervention policies are adopted in order
to reduce the spread of the virus in horse
populations.4
At present, the conventional
laboratorial methods available in Brazil for
the diagnosis of ER include virus isolation
(VI) with confirmation of  its identity and
serological tests.5,6  However, these methods
have many limitations, as viral antigens or
virus-specific antibodies cannot be detected,
thus making the presence of viral genome
the only evidence of  EHV-1 infection.
Because of this, the polymerase chain
reaction (PCR) techniques have been applied
for the detection of  EHV-1 DNA from
clinical and cell culture samples.  This
technique is rapid, sensitive and does not
depend on the presence of  a viable virus.
Also, local antibodies do not interfere with
this nucleic acid amplification method.
Moreover, the nested PCR test, utilizing an
inner set of primers in a second round of
amplification, has been adopted, thus
resulting in an increase of the sensitivity and
the specificity for the identification of the
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EHV-1 DNA sequences without subsequent
specification with restriction endonuclease
digestion or Southern blot hybridization of
the amplified products.3,7,8
EHV-1 shedding in nasal secretions
as well as its spreading in respiratory and
lymphoid tissues after experimental infection
in horses is well established.9,10  However, to
our knowledge, there have been few
published reports concerning EHV-1
distribution detected by PCR in the
bronchoalveolar lavage fluid (BALF) cells
and peripheral blood leucocytes (PBL)
samples immediately after experimental
virus inoculation of  horses.  Published data
available are limited and refer only to
detection of  latent EHV-1 infection.11,12  The
main purpose of this experiment was to
study the distribution of  the EHV-1 in these
cell populations using this diagnostic tool
before and after the experimental viral
inoculation of  horses.  In addition, we also
described the clinical, hematological and
serological responses of  horses to the EHV-
1 challenge.
Materials and Method
The Brazilian A4/72 strain of
EHV-1 (Instituto Biológico, São Paulo, SP,
Brazil), originally obtained from an aborted
equine fetus, was used in the 15th passage
level in Vero cells for all experiments.
Seven conventional horses (six
geldings and one mare), aged 8-16 years, were
inoculated intranasally with 106.6 TCID50/mL
of  EHV-1.  For a minimum period of  three
weeks prior to the experimental challenge,
serological monitoring ruled out any
possibility of  concurrent field EHV-1
infection (Table 1).  All these horses were
kept in separate stalls that did not allow
aerosol circulation among animals in the
study.  They were bedded on shavings and
fed on pelleted concentrates and dust-free
hay.  The experimental animal procedures
were approved by the ethical committee of
the Faculdade de Medicina Veterinária da
Universidade de São Paulo (protocol 240/
2002) and the facilities and environment
conditions followed the guidelines of
the C.C.A.C.13.
Rectal temperature and clinical
manifestations were recorded daily, in the
morning and evening, for 10 days
after EHV-1 inoculation.  Endoscopic
examinations of URT were conducted once
before inoculation and during the immediate
post-challenge period by using a 180-cm
fiberoptic endoscope (CF-LB2, Olympus,
Table 1 - Serum virus neutralizing (VN) antibody titers of horses before and after inoculation with EHV-1 strain
A4/72.  (n = 7) - São Paulo - 2005
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Tokyo, Japan).  Blood samples (with 2mg
EDTA/mL) were collected daily for 10 days
for total and differential WBC counts that
were measured by standard procedures.
Bronchoalveolar lavage (BAL).  BAL
was performed using silicone catheter
(Bivona Inc., Gary, IN, USA) as previously
described by Mori et al.14. Repeated BALs
were performed with at least seven days of
interval: –7, +2, +9, +16, +23 and +30 days
post-inoculation (dpi).  The cytological slides
were prepared as described.14
Isolations of virus were attempted
from nasal swabs taken on the first, second,
third, fourth, fifth, seventh and ninth dpi and
from PBL collected from 20 mL of whole
blood (with 2 mg EDTA/mL) daily for 10
dpi.  These specimens were placed in the
Eagle’s minimal essential medium (MEM)
plus 10% of fetal bovine serum and after
that inoculated in Vero culture cells.  When
these cells exhibited cytopathic effect (CPE),
the identification of isolates could be
performed as described by Saxegaard.15
Serum was taken before viral
inoculation and, afterwards, periodically
every seven days for four weeks for the
detection of neutralizing antibodies against
EHV-1 (expressed as log10 values) using the
microtitration method, as previously
described5.  Seroconversions were defined
as increases of four-fold (or 0.6 log10) of
VN antibody titers between acute and
convalescent serum samples.16
DNA, isolated from PBL and BALF
samples, was extracted following a method
described elsewhere.17  The primer pairs
were selected based on the nucleotide
sequences of the glycoprotein B (gB) region
of  EHV-1 and EHV-4 genomes described
by Kirisawa et al.18 and were predicted to
yield PCR products for outer (FC2-RC) and
inner (FC2-R1 and FC2-R4) primers
(Invitrogen Brasil Ltda, São Paulo, SP, Brazil)
as shown in table 2.
The amplification conditions were
performed in a reaction mixture of  total
volume 50μl containing 100ng of DNA
sample, 0.5μM of each primer (outer
primers), 0.2mM of each dNTP mixture,
2.5 units of  Taq DNA polymerase
(Invitrogen Brasil Ltda, São Paulo, SP, Brazil),
1´ PCR buffer (20mM of  Tris-HCl pH 8.4,
50mM of KCl), 1.5mM of MgCl2 and
milliQ water QS.  Amplification was carried
out in a thermal cycler (PTC-200, Bio-Rad
Laboratories Inc., Waltham, MA, USA)
under the following conditions: DNA
template was initially denatured at 94°C for
5-min followed by 35 cycles of 1-min
denaturation at 94°C, 1 min primer annealing
at 60°C and 1-min extension at 72°C. Lastly,
the reaction was completed in a 7-min final
extension step at 72°C. For the semi-nested
PCR, 1μl of the primary amplification
template was added to 49μl of a reaction
mixture containing the inner primers, and the
thermal cycles program was repeated.  Both
positive viral DNA (EHV-1 strain A4/72)
and negative (water) controls were run for
all PCR assays.  The PCR products were
loaded onto 1% agarose gel and
electrophoresis carried out at 100V for 70-
min in TAE buffer.  The gel was stained with
Table 2 - Nucleotide sequences of primers used for EHV-1 and EHV-4 differentiation and PCR fragment size18
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0.5μg/mL ethidium bromide and DNA
bands were visualized on UV
transilluminator.  Negative amplifications
were repeated at least once in order to detect
the presence of  PCR inhibitors.
Precautions were adopted in order to
avoid cross-contamination due to
manipulation of PCR products such as:
physical separation of DNA extraction, pre-
PCR and post-PCR amplifications; exclusive
positive displacement pipettes and aerosol
filtered pipette tips.
To determine the analytical sensitivity,
EHV-1 strain A4/72 with 10-3/25µl TCID50
was serially 10-fold diluted.  The 460bp
second round product was detected at a
dilution of 10-9, the highest dilution returning
a positive semi-nested PCR result.
Data analysis (serum VN antibody
titers and BALF differential cell counts) was
performed using a statistical software Graph
Pad InStat version 3.01, 32 bit for Windows
95/NT.  Each variable was tested for
normality applying the Kolmogorov and
Smirnov method. One way analysis of
variance (ANOVA) was used to compare
means, for data normally distributed.  If  data
did not seem to be normally distributed,
Kruskal-Wallis test was used. The level of
statistical significance was set at P<0.05.
Results
On the day following the viral
challenge, all horses simultaneously showed
some clinical manifestations of disease:
bilateral serous ocular and nasal discharges,
hyperemia of the conjunctival and ocular
mucous membranes and enlargement of
submandibular lymph nodes.  The intensity
of these signs was at its peak between days
3 and 5; afterwards it was minimal on day 8
and lastly disappeared on day 10.  Between
days 3 and 5, endoscopic findings indicated
increased amounts of mucus in the pharynx
and larynx.  Nevertheless, there was no
increase in rectal temperature nor evidence
of  more severe complications of  EHV-1
infection (i.e. respiratory distress or systemic
illness).  The total and differential WBC
counts during the whole trial remained within
the normal reference range described for the
specie.
As it can be seen in table 3, there was
a predominance of macrophages (31 – 90%)
and lymphocytes (10 – 50.5%) in the BALF
samples obtained from healthy horses (-7
dpi).  Neutrophils comprised less than 10%
in the BALF samples of all healthy horses
except for H5 and H6, which exhibited
elevated numbers of these cells before
inoculation.  After challenge, there was no
significance difference in any of the BALF
cytological counts.  However, during the
convalescence phase of viral infection, the
horses H3, H4 and H7 showed a marked
rise in neutrophil values.
No virus was recovered from PBL
and nasal swab samples at any time after the
inoculation.  The pre-inoculation and post-
inoculation serum VN antibody titers are
given in table 1.  There was no statistically
significant difference in VN antibody levels
from horses infected with EHV-1.
Nevertheless, the horses H2, H5, H6 and H7
seroconverted to EHV-1 by 14 and 21 dpi.
The horses H1 and H4 also showed also a
slight rise of post-challenge serum antibodies
that was insufficient to be named
seroconversion.
According to table 4, the EHV-1
DNA was detected through the PCR from
PBL samples of all horses within the third
to the eighth day after the inoculation.  In
addition, as shown in table 5, the PCR assay
detected the DNA virus in BALF samples
starting on the ninth day after the
experimental infection in horses H2, H6 and
H7. Horse H4 was positive from day 2,
while horse H5 was positive only after 23
days.  However, no amplification was
detected for EHV-4 from any PBL and
BALF samples.
Discussion
In the first ten days after the
inoculation, all the animals showed signs of
a mild, transient and self-limiting URT
infection.  These findings were very similar
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Table 3 - Differential cell counts of leukocytes recovered by bronchoalveolar lavage fluid (BALF) samples of horses
before and after inoculation with EHV-1 strain A4/72.  (n = 7) - São Paulo - 2005
Table 4 - Results of the semi-nested PCR assay to detected EHV-1 DNA performed on peripheral blood leucocytes
(PBL) samples - São Paulo - 2005
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to the results obtained from horses after
experimental EHV-1 re-infections of  the
respiratory tract.1,19,20  It seems evident that
the presence of local immunity tends to
reduce the viral multiplication of  URT, and
consequently the damage to this tissue.21,22
Based on hematologic results, no
animal developed transient blood
leukopenia, involving lymphocytes as well as
neutrophils.  Moreover, other hematological
changes such as reactive lymphocytes,
considered an indicator of active virus
infection, were not observed in the present
study either.  This work supports the earlier
observations that horses exposed to
infection on numerous occasions showed less
severe illness.1,19
From table 3 it may be inferred that
in the majority of cases the fluctuation of
leukocyte populations in the bronchoalveolar
compartment cells was not related to an
EHV-1 infection.  Unlike what was described
by Kydd, Hannant and Mumford23, no horse
showed a transient BALF neutrophilia during
the acute viral infection phase.  This absence
of leukocyte recruitment to the affected
areas in the peripheral circulation and
bronchoalveolar compartment may be
associated with reduced signs of  EHV-1
infection.  In addition, we could not find
other cytological changes considered
consistent with viral respiratory disease, such
as lymphocyte responses in BALF samples,
contrasting with other published studies.14,24
In this trial, the BALF neutrophil
numbers of two healthy horses (H5 and H6)
were higher than those described
previously.23  When the value of  neutrophils
in BALF of healthy horses is higher than 10%
it can be related to several factors, such as
stabling25 and aging (>6 years) .26
Results of  this study also suggested
that the pulmonary neutrophilic influx
observed in BALF samples of  horses H3,
H4 and H7 during the convalescence viral
infection phase may be induced by sequential
lavages.  According to Traub-Dargatz et al.27
and Sweeney et al.28, the constituents of saline
solution used for lavage and BAL technique
may contribute to lung inflammation.
It can be seen in table 1 that
seroconversion was observed in horses H5,
H6 and H7 even in the presence of high levels
of VN antibodies before the trial.  On the
other hand, the results of horses H1, H3 and
H4 were similar to those described by other
investigators, in which reported responses of
serum VN to EHV-1 re-infections have
usually been absent.21,29
In this study, there were no viruses
recovered by VI from either nasal swabs or
PBL of any horses after inoculation with
EHV-1.  This failure of  VI was probably
due to the low level of infectious virus19.  The
duration and amount of virus can be
reduced in animals with high levels of
circulating VN antibody as a result of
previous exposure.20,21
Despite serum VN antibodies were
not detected in horse H2 before experimental
infection (Table 1), EHV-1 could not be
isolated from nasal swab, suggesting that
protective immunity against clinical disease
and viral shedding depend on several factors,
beside the humoral response. Additional
mechanisms, such as CD8+ cytotoxic T
lymphocytes, are responsible for the
protective immunity against EHV-1 infection
and essential for suppression of viral
replication.14, 20
On the other hand, as it can be
observed in table 4, the EHV-1 DNA was
detected from PBL in the majority of the
horses within the third to the eighth day after
inoculation.  It seems that all horses sampled
in this study were viremic after the challenge
and it can also be inferred that the PCR was
a more sensitive diagnostic tool than VI in
detecting virus from PBL samples.
PCR patterns from PBL samples
showed an intermittent EHV-1 viremia in
horses H2, H3, H5, H6 and H7, suggesting
a moderate level of  viral activity. This
oscillation in EHV-1 amount could lead a
low virus load, below of  semi-nested PCR’s
detection limit.
According to table 5, it appears that
there was the dissemination of  the EHV-1
throughout the respiratory tract after virus
exposure in horses H2, H4, H5, H6 and H7.
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In contrast, previous reports indicated that the
detection of  EHV-1 was less extensive in
lavaged bronchoalveolar cells than in lymphoid
tissues11,12 and PBL11.  Because of that, the
detection of positive PCR product in the
BALF following the EHV-1 challenge suggests
that the animals in this study become infected.
Nevertheless, whether EHV-1 survives
in the convalescent animal as a persistent (active
virus replication) or latent virus infection is not
known either from BALF or PBL samples.
It is known that the differentiation between
active and latent infection may be important
for management control and treatment of
EHV-1 infected horses.  And as the
conventional PCR technique used in this work
does not allow the differentiation between these
two states of  EHV-1 in positive samples,
Table 5 - Results of the semi-nested PCR assay to detected EHV-1 DNA performed on bronchoalveolar lavage fluid
(BALF) samples - São Paulo - 2005
further studies should be carried out, such as
the quantitative real-time PCR assay30 and the
identification of latency associated transcripts
(LATs) expression in RNA by RT-PCR31,32.
Despite the significance of  EHV-4
as respiratory pathogen in horse populations
worldwide1,2, all clinical samples in present
work were negative for EHV-4 detection by
PCR.  As observed by Carvalho et al.3,
the role of  EHV-4 in Brazilian horses remains
to be investigated.
Based on the results obtained from
this study, it can be affirmed that the PCR is a
highly effective technique in detecting the
EHV-1. It may be used in circumstances where
traditional methods are not efficient due to
the fact that it provides an enhanced diagnostic
procedure for underdiagnosed diseases.
Detecção do DNA do herpesvírus eqüino 1 pela reação em cadeia pela
polimerase em cavalos inoculados com a estirpe brasileira A4/72
Resumo
Sete cavalos adultos de status sanitário convencional foram inoculados
por via intranasal com a estirpe brasileira A4/72 do herpesvírus eqüino
tipo 1 (EHV-1). Nos primeiros dez dias após a inoculação viral, todos
os cavalos apresentaram manifestações de infecção respiratória leve e
restrita às vias aéreas anteriores. Apesar de possuírem títulos de
anticorpos neutralizantes antes da inoculação, alguns cavalos
apresentaram soroconversão após o desafio viral. O EHV-1 não foi
isolado a partir das secreções nasais e leucócitos sanguíneos periféricos
(PBL) de nenhum animal. Entretanto, o DNA viral foi detectado pela
Palavras-chave:
Cavalos.
Herpesvirus eqüino tipo 1.
Diagnóstico.
Reação em cadeia pela polimerase.
PCR.
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reação em cadeia pela polimerase (PCR) nos PBL entre o terceiro e o
oitavo dias pós-inoculação (d.p.i.) em todos os animais, indicando a
ocorrência de viremia. Além disso, a prova de PCR detectou o vírus
nas amostras do lavado broncoalveolar a partir do nono d.p.i. na
maioria dos animais. Com base nos resultados obtidos, foi possível
concluir que a PCR é uma técnica com alta sensibilidade e especificidade
para o diagnóstico do EHV-1, capaz de detectar a presença do DNA
viral mesmo quando não ocorre a constatação do agente pelos
métodos tradicionais.
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